StockData
Zoetis Inc. logo

Zoetis Inc. (ZTS) stock

ZTSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 17/3047% below fair value
$79.11−1.68 (-2.08%)

Close on Nov 20, 2026Market cap $32.69BP/E 13.0Yield 2.57%

Zoetis free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Zoetis's free cash flow for the twelve months ending Jun 30, 2026 was $2.32B, up 2.1% year over year. For fiscal 2025 it was $2.28B, down 0.7% from the year before. Over ten years it grew 17.9% a year on average. The highest annual figure on record is $2.30B in fiscal 2024.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.28B-0.7%
FY2024Dec 31, 2024$2.30B+41.8%
FY2023Dec 31, 2023$1.62B+22.2%
FY2022Dec 31, 2022$1.33B-23.6%
FY2021Dec 31, 2021$1.74B+3.8%
FY2020Dec 31, 2020$1.67B+25.3%
FY2019Dec 31, 2019$1.34B-8.1%
FY2018Dec 31, 2018$1.45B+29.4%
FY2017Dec 31, 2017$1.12B+125.8%
FY2016Dec 31, 2016$497.00M+13.0%
FY2015Dec 31, 2015$440.00M-1.3%
FY2014Dec 31, 2014$446.00M-10.3%
FY2013Dec 31, 2013$497.00M+51.5%
FY2012Dec 31, 2012$328.00M-9.4%
FY2011Dec 31, 2011$362.00M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$538.00M+17.2%
Q1 FY2026Mar 31, 2026$291.00M-13.6%
Q4 FY2025Dec 31, 2025$732.00M+6.2%
Q3 FY2025Sep 30, 2025$755.00M-3.7%
Q2 FY2025Jun 30, 2025$459.00M+24.1%
Q1 FY2025Mar 31, 2025$337.00M-25.9%
Q4 FY2024Dec 31, 2024$689.00M-1.4%
Q3 FY2024Sep 30, 2024$784.00M+35.4%
Q2 FY2024Jun 30, 2024$370.00M+2076.5%
Q1 FY2024Mar 31, 2024$455.00M+39.6%
Q4 FY2023Dec 31, 2023$699.00M+22.6%
Q3 FY2023Sep 30, 2023$579.00M+55.6%
Q2 FY2023Jun 30, 2023$17.00M-91.1%
Q1 FY2023Mar 31, 2023$326.00M+68.0%
Q4 FY2022Dec 31, 2022$570.00M+11.5%
Q3 FY2022Sep 30, 2022$372.00M-30.3%
Q2 FY2022Jun 30, 2022$190.00M-48.4%
Q1 FY2022Mar 31, 2022$194.00M-39.9%
Q4 FY2021Dec 31, 2021$511.00M-9.7%
Q3 FY2021Sep 30, 2021$534.00M+20.0%
Q2 FY2021Jun 30, 2021$368.00M+5.7%
Q1 FY2021Mar 31, 2021$323.00M+2.9%
Q4 FY2020Dec 31, 2020$566.00M+36.1%
Q3 FY2020Sep 30, 2020$445.00M+17.7%
Q2 FY2020Jun 30, 2020$348.00M+61.9%
Q1 FY2020Mar 31, 2020$314.00M-3.7%
Q4 FY2019Dec 31, 2019$416.00M-6.7%
Q3 FY2019Sep 30, 2019$378.00M-20.6%
Q2 FY2019Jun 30, 2019$215.00M+10.8%
Q1 FY2019Mar 31, 2019$326.00M-3.0%
Q4 FY2018Dec 31, 2018$446.00M-15.0%
Q3 FY2018Sep 30, 2018$476.00M+21.7%
Q2 FY2018Jun 30, 2018$194.00M+50.4%
Q1 FY2018Mar 31, 2018$336.00M+336.4%
Q4 FY2017Dec 31, 2017$525.00M+132.3%
Q3 FY2017Oct 1, 2017$391.00M+114.8%
Q2 FY2017Jul 2, 2017$129.00M–
Q1 FY2017Apr 2, 2017$77.00M–
Q4 FY2016Dec 31, 2016$226.00M–
Q3 FY2016Oct 2, 2016$182.00M–

More Zoetis figures

See a number that looks wrong?